Public Calendar: November 30 - December 6, 2025
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs
Event Date: 12/02/2025
Location: Miami, FL
Subject: Citi's 2025 Global Healthcare Conference
FDA Participant/Group: KYLE DIAMANTAS;
Non FDA Participant/Group: Industry, biotech, medical technology, and life sciences
Event Date: 12/04/2025
Location: New York, NY
Subject: Piper Sandler 37th Annual Healthcare Conference; Speaker: Transparency and the Role it Plays in FDA Interactions with Drug Developers
FDA Participant/Group: MICHELLE TARVER; JOSHUA PRADKO; SAMUEL DORAN;
Non FDA Participant/Group: Industry
Event Date: 12/05/2025
Location: Washington, DC
Subject: Research and Development Leader Forum
FDA Participant/Group: SAMUEL DORAN; JAMES TRAFICANT;
Non FDA Participant/Group: John C. Reed (Johnson and Johnson); Dean Li (Merck); James Bradner (Amgen); Tadaaki Taniguchi (Astellas Pharma); Daniel M. Skovronsky (Eli Lilly);
Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs
No Significant Event
Official Name: Sean R. Keveney, Chief Counsel
No Significant Event
Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods
Event Date: 12/02/2025
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Staff and members of the National Association of State Departments of Agriculture
Event Date: 12/04/2025
Location: Washington, DC
Subject: Dietary Supplement Issues of Mutual Interest
FDA Participant/Group: CARA WELCH;
Non FDA Participant/Group: Council for Responsible Nutrition Board of Directors
Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations
No Significant Event
Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
Event Date: 12/04/2025
Location: Virtual
Subject: Labeling of Drugs Used for Medically Assisted Suicide
FDA Participant/Group: LUKE HALL; KARIM MIKHAIL;
Non FDA Participant/Group: Barbara Lyons (Patients' Rights Action Fund); Joseph Marine (APCO Worldwide);
Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research
Event Date: 12/03/2025
Location: Boston, MA
Subject: Harvard University Lecture for Frontiers in Therapeutics: Science of Health Course
FDA Participant/Group: N/A
Non FDA Participant/Group: Harvard staff and students
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Richard Pazdur, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products
No Significant Event
Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine
Event Date: 12/03/2025
Location: College Park, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: MATTHEW LUCIA; WILLIAM FLYNN;
Non FDA Participant/Group: Holger Lehmann, Richard DeLuca (Merck Animal Health);
Event Date: 12/04/2025
Location: Washington, DC
Subject: Animal Health Institute Board of Directors' Breakfast
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of Animal Health Institute (AHI)